Abstract
Purpose AIM-Back is an embedded pragmatic clinical trial (ePCT) with cluster randomization designed to increase access and compare the effectiveness of two different non-pharmacological care pathways for low back pain (LBP) delivered within the Veteran Administration Health Care System (VAHCS). This manuscript describes baseline characteristics of AIM-Back participants as well as the representativeness of those referred to the AIM-Back program by sex, age, race, and ethnicity, relative to Veterans with low back pain at participating clinics.
Participants To be eligible for AIM-Back, Veterans were referred to the randomized pathway at their clinic by trained primary care providers (Referral cohort). Veterans from the Referral cohort that participated in the study included: 1) an Electronic Health Record (EHR) sample of Veterans enrolled in the program (i.e., attended initial AIM-Back visit with no consent required) and a Survey sample of Veterans that were consented for further study. Descriptive statistics for age, race, ethnicity, sex, high-impact chronic pain (HICP), a comorbidity measure, post-traumatic stress diagnosis (PTSD) and opioid exposure were reported for the Referral cohort and by sample; mean baseline PROMIS pain interference, physical function and sleep disturbance scores were reported by sample. Additional measures of pain, mental health and social risk were reported on the Survey sample. Participation to prevalence ratios (PPRs) were calculated for sex, age, race, and ethnicity by clinic to describe representativeness of the Referral cohort.
Findings to Date Across 17 randomized primary care clinics, the Referral cohort included 2767 unique Veterans with n=1817 in the EHR sample, n=996 in the Survey sample and n=799 of the EHR sample (44%) were also in the Survey sample. High rates of HICP were observed in the EHR and Survey samples (>59%). Mean scores (SD) based on self-reported PROMIS Pain Interference (63.2 (6.8), 63.1 (6.6)) and PROMIS Physical Function (37.1 (5.3), 38.1 (5.8)) indicated moderate impairment in the EHR sample and Survey sample respectively. Approximately 10% of the EHR sample had documented opioid use in the year leading up to the AIM-Back referral. At most clinics, older Veterans (>=65 years) were underrepresented in the Referral cohort compared to those with LBP visits at clinics (PPRs < 0.8).
Future Plans The AIM-Back trial will conduct analysis to examine the comparative effectiveness of the two care pathways and identify individual characteristics that may improve responses to each pathway. The trial is expected to complete 12-month follow-up data collection by December 2024, with subsequent analyses and publications providing insights into optimizing non-pharmacological care for Veterans with LBP.
Trial Registration NCT04411420 (clinicaltrials.gov)
Strengths
Embedded features (e.g., EHR documentation and clinical staff serving as interventionist) of the AIM-Back trial have potential to facilitate implementation of these care pathways more broadly in Veteran’s Health Administration clinics and in health systems outside the Veteran’s Health Administration
Participating clinics were in 10 states providing regional geographic representation across the study.
Trial was delivered within an integrated health system optimal for consistent documentation templates and data extraction across the trial sites.
Limitations
Due to clinical personnel’s role in participant recruitment, sample biases may exist in those referred to the program and/or those who agreed to participate in additional surveys
These findings may not be generalizable to older aged Veterans due to our lower enrollment of those 65+.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04411420
Funding Statement
This work is supported through cooperative agreement UH3AT009790 from the NIH, National Center for Complimentary and Integrative Health (NCCIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health the U.S Department of Veterans Affairs or the United States Government This manuscript is a product of the Pain Management Collaboratory. For more information about the Collaboratory, visit https://painmanagementcollaboratory.org/. This material is the result of work supported with resources and the use of facilities at the Durham VA Health Care System in Durham North Carolina.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Duke University and Durham VA gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
courtni.france{at}va.gov, cynthia.coffman{at}duke.edu, kdallen{at}email.unc.edu, trevor.lentz{at}duke.edu, Rebecca.north13{at}duke.edu, ashley.choate{at}va.gov, adam.goode{at}duke.edu, corey.simon{at}duke.edu, janet.grubber{at}va.gov, heather.king{at}duke.edu, chad.cook{at}duke.edu, francis.keefe{at}duke.edu, lindsay.ballengee{at}duke.edu, jennifer.naylor{at}duke.edu, joseph.l.brothers{at}duke.edu, catherine.stanwyck{at}va.gov, travis.linton{at}duke.edu, christa.tumminello{at}va.gov, susan.hastings{at}duke.edu
Data Availability
All data produced in the present study are available upon reasonable request to the authors, after the primary outcomes are reported in a peer-reviewed manuscript
